Lexpos News

/Lexpos News/

NHSE opens EOI process for additional capacity for C-19 vacs service

NHS England has announced a new expression of interest (EOI) process for pharmacy owners that wish to take part in the COVID-19 Vaccination Service from a location away from their pharmacy and are able to assist with the provision of further fixed sites services and/or outreach vaccination services. Each NHS England regional teams will determine what services [...]

The post NHSE opens EOI process for additional capacity for C-19 vacs service appeared first on Community Pharmacy England.

By |July 11th, 2024|Lexpos News|Comments Off on NHSE opens EOI process for additional capacity for C-19 vacs service

Health Secretary announces mission to improve the health of the nation

Yesterday, new Secretary of State for Health and Social Care Wes Streeting announced plans for his Department to expand its focus to boost economic growth, which includes an objective to cut waiting times and improve public health. This is in line with Labour’s health mission, which Community Pharmacy England has been considering for some time. [...]

The post Health Secretary announces mission to improve the health of the nation appeared first on Community Pharmacy England.

By |July 10th, 2024|Lexpos News|Comments Off on Health Secretary announces mission to improve the health of the nation

Updated Incident Reporting Approved Particulars

The Incident Reporting Approved Particulars were due to be updated on NHS England’s website this week, but we understand that this has now been delayed until the end of July. This is a change to the timing announced in last week’s Primary Care Bulletin. The clinical governance requirements of the community pharmacy contractual framework (CPCF) [...]

The post Updated Incident Reporting Approved Particulars appeared first on Community Pharmacy England.

By |July 9th, 2024|Lexpos News|Comments Off on Updated Incident Reporting Approved Particulars

MHRA Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited))

Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) Drug alert number: EL (24)A/27 Date issued: 9 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) Company name: Chelonia Healthcare Limited [...]

The post MHRA Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited)) appeared first on Community Pharmacy England.

By |July 9th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Propantheline Tablets 15mg (Genesis Pharmaceuticals livery (Chelonia Healthcare Limited))

South East and South West Pharmacy Owners: Book your place for our regional roadshows

Whatever the outcome of the 2024 General Election, the next Government and its approach to community pharmacy will be critical for the future of the sector. Pharmacy owners across the South East and South West are invited to hear more about what lies ahead for community pharmacy, and how Community Pharmacy England will be working [...]

The post South East and South West Pharmacy Owners: Book your place for our regional roadshows appeared first on Community Pharmacy England.

By |July 9th, 2024|Lexpos News|Comments Off on South East and South West Pharmacy Owners: Book your place for our regional roadshows